NCT07006259

Brief Summary

To evaluate the effects of a foot treatment to improve balance according to the Bobath Concept in people with Multiple sclerosis, comparing it with treatment through home exercise and with treatment from Bobath Concept combined with the use of virtual reality. As a secondary objective, we seek to know the state of the art of Bobath therapy in Multiple Sclerosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 26, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 26, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 26, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 7, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

June 5, 2025

Completed
Last Updated

June 5, 2025

Status Verified

May 1, 2025

Enrollment Period

4 months

First QC Date

May 7, 2025

Last Update Submit

May 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Balance Evaluation Systems Test (Mini BESTest).

    It assesses balance in six items (biomechanical restrictions, stability and verticality limits, anticipatory postural adjustments, postural responses, sensory orientation, and gait stability). It has excellent inter- and intra-observer reliability and construct validity in stroke patients. Furthermore, the items on anticipatory postural adjustments and sensory orientation are highly correlated with the risk of falls in this type of pathology.

    At the beginning, at the month and we would reevaluate after 15 days

Secondary Outcomes (1)

  • Timed Up and Go Test

    At the beginning, at the month and we would reevaluate after 15 days

Other Outcomes (5)

  • Functional reach test (FRT)

    At the beginning, at the month and we would reevaluate after 15 days

  • Modified Fatigue Impact Scale (MFIS)

    At the beginning, at the month and we would reevaluate after 15 days

  • MusiQoL

    At the beginning, at the month and we would reevaluate after 15 days

  • +2 more other outcomes

Study Arms (3)

Control group

EXPERIMENTAL

Treatment with bobath Therapy

Other: Bobath Therapy

Experimental group A

ACTIVE COMPARATOR

Bobath Therapy plus Virtual Reality

Other: Bobath therapy plus virtual reality

Experimental group B

ACTIVE COMPARATOR

Home exercises

Other: Home exercises

Interventions

Treatment with bobath therapy

Control group

Treatment with bobath therapy plus virtual reality

Experimental group A

Treatment with home exercises

Experimental group B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: over 18 years old.
  • Have a diagnosis of multiple sclerosis, according to Mc Donald criteria at least 6 months before the start of the intervention.
  • Be able to walk independently in a closed environment with or without technical aids, having a maximum score of 6.5 on the Expanded Disability Status Scale or EDSS, according to its acronym in English:
  • = constant bilateral help (canes, crutches or braces) to walk about 20 meters without rest. The usual functional system (FS) is equivalent to combinations with more than two FS of grade 3+.

You may not qualify if:

  • Participants who are not able to understand instructions,
  • Participants who are in a clinically unstable situation or who have risk factors or concomitant pathologies of the musculoskeletal system, neurological or cardiovascular, which make it difficult to carry out the treatment.
  • Participants with visual disturbances or severe upper limb involvement who therefore have difficulty using the VR glasses or performing reaching exercises with them.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Rey Juan Carlos

Alcorcón, Madrid, 28922, Spain

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 7, 2025

First Posted

June 5, 2025

Study Start

September 26, 2024

Primary Completion

January 26, 2025

Study Completion

March 26, 2025

Last Updated

June 5, 2025

Record last verified: 2025-05

Locations